Author
Ronghui Liang
Also Known As
R. Liang, RONGHUI LIANG, Rong-Hui Liang, Ronghui Liang
34
Publications
3.1K
Citations
20
H-Index
33
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 8 | 8 | 487 |
2 | Immunology | 4 | 4 | 297 |
3 | Cell Biology | 3 | 3 | 121 |
4 | Biochemistry | 1 | 1 | 31 |
5 | Molecular Biology | 1 | 1 | 16 |
Ronghui Liang
×
26
Publications
3K
Citations
20
H-Index
| Year | Citations | |
|---|---|---|
2020 | 1.2K | |
2020 | 557 | |
2022 | 215 | |
2021 | 200 | |
2020 | 139 | |
Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system Shuofeng Yuan, Jasper Fuk‐Woo Chan, Kenn Ka-Hang Chik, Drug SafetyFda-approved Drugs BexarotenePreclinical Drug EvaluationMedicineAntiviral Therapy | 2020 | 71 |
2020 | 69 | |
2020 | 63 | |
2019 | 62 | |
2020 | 62 |
Page 1
Page 1